Compare Boston Scientific Corporation (BSX) vs Royal Bank of Canada (RY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Royal Bank of Canada — how do they compare? Boston Scientific Corporation trades at $50.96 (market cap $74.19B), while Royal Bank of Canada trades at $210.44 (market cap $292.32B). The key difference: Royal Bank of Canada is far larger — about 3.9× Boston Scientific Corporation's market cap, and Royal Bank of Canada pays a 2.37% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | RY | |
|---|---|---|
Market Cap | $74.19B | $292.32B |
Sector | Health | Financials |
52-Week High | $108.14 | $217.87 |
52-Week Low | $42.63 | $134.80 |
Enterprise Value | $86.27B | — |
Dividend Yield | — | 2.37% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →
